nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP19A1—uterine cancer	0.373	1	CbGaD
Methadone—OPRK1—Progesterone—uterine cancer	0.09	0.187	CbGbCtD
Methadone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0389	0.0807	CbGbCtD
Methadone—CYP3A7—Progesterone—uterine cancer	0.0357	0.0741	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0357	0.0741	CbGbCtD
Methadone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0271	0.0563	CbGbCtD
Methadone—CYP3A5—Progesterone—uterine cancer	0.0268	0.0556	CbGbCtD
Methadone—CYP2C8—Progesterone—uterine cancer	0.0258	0.0534	CbGbCtD
Methadone—CYP2C19—Progesterone—uterine cancer	0.0216	0.0448	CbGbCtD
Methadone—CYP1A2—Progesterone—uterine cancer	0.02	0.0414	CbGbCtD
Methadone—CYP2C9—Progesterone—uterine cancer	0.018	0.0373	CbGbCtD
Methadone—ABCB1—Progesterone—uterine cancer	0.0174	0.0362	CbGbCtD
Methadone—CYP2D6—Progesterone—uterine cancer	0.0164	0.0341	CbGbCtD
Methadone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0158	0.0327	CbGbCtD
Methadone—ABCB1—Dactinomycin—uterine cancer	0.0138	0.0287	CbGbCtD
Methadone—CYP3A5—Etoposide—uterine cancer	0.012	0.0249	CbGbCtD
Methadone—CYP2C8—Etoposide—uterine cancer	0.0115	0.0239	CbGbCtD
Methadone—CYP3A4—Progesterone—uterine cancer	0.0105	0.0217	CbGbCtD
Methadone—CYP2B6—Doxorubicin—uterine cancer	0.0104	0.0215	CbGbCtD
Methadone—CYP1A2—Etoposide—uterine cancer	0.00893	0.0185	CbGbCtD
Methadone—ABCB1—Etoposide—uterine cancer	0.00781	0.0162	CbGbCtD
Methadone—CYP19A1—corpus luteum—uterine cancer	0.00676	0.261	CbGeAlD
Methadone—ABCB1—Doxorubicin—uterine cancer	0.00532	0.011	CbGbCtD
Methadone—CYP2D6—Doxorubicin—uterine cancer	0.00502	0.0104	CbGbCtD
Methadone—CYP3A4—Etoposide—uterine cancer	0.00468	0.0097	CbGbCtD
Methadone—CYP3A4—Doxorubicin—uterine cancer	0.00319	0.00661	CbGbCtD
Methadone—CYP19A1—semen—uterine cancer	0.00317	0.122	CbGeAlD
Methadone—CYP2C18—uterine cervix—uterine cancer	0.00112	0.043	CbGeAlD
Methadone—CHRNA10—vagina—uterine cancer	0.0011	0.0424	CbGeAlD
Methadone—CYP2C18—mammalian vulva—uterine cancer	0.000977	0.0376	CbGeAlD
Methadone—OPRD1—renal system—uterine cancer	0.000945	0.0364	CbGeAlD
Methadone—CYP2C18—vagina—uterine cancer	0.000757	0.0292	CbGeAlD
Methadone—OPRK1—female reproductive system—uterine cancer	0.000725	0.028	CbGeAlD
Methadone—CHRNA10—lymph node—uterine cancer	0.000711	0.0274	CbGeAlD
Methadone—Clotrimazole—CYP11A1—uterine cancer	0.000568	0.325	CrCbGaD
Methadone—CYP19A1—endometrium—uterine cancer	0.000523	0.0202	CbGeAlD
Methadone—CYP19A1—uterus—uterine cancer	0.000482	0.0186	CbGeAlD
Methadone—CYP19A1—female reproductive system—uterine cancer	0.000434	0.0167	CbGeAlD
Methadone—Lung disorder—Epirubicin—uterine cancer	0.000398	0.00428	CcSEcCtD
Methadone—CYP19A1—female gonad—uterine cancer	0.000395	0.0152	CbGeAlD
Methadone—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000389	0.00418	CcSEcCtD
Methadone—CYP2C8—renal system—uterine cancer	0.000388	0.0149	CbGeAlD
Methadone—Redness—Doxorubicin—uterine cancer	0.000386	0.00415	CcSEcCtD
Methadone—Vertigo—Progesterone—uterine cancer	0.000385	0.00415	CcSEcCtD
Methadone—Syncope—Progesterone—uterine cancer	0.000385	0.00414	CcSEcCtD
Methadone—Palpitations—Progesterone—uterine cancer	0.000379	0.00408	CcSEcCtD
Methadone—Loss of consciousness—Progesterone—uterine cancer	0.000377	0.00406	CcSEcCtD
Methadone—CYP2C8—endometrium—uterine cancer	0.000375	0.0144	CbGeAlD
Methadone—CYP3A5—uterine cervix—uterine cancer	0.000374	0.0144	CbGeAlD
Methadone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000374	0.00402	CcSEcCtD
Methadone—Cardiac failure—Etoposide—uterine cancer	0.000373	0.00402	CcSEcCtD
Methadone—Convulsion—Progesterone—uterine cancer	0.000372	0.004	CcSEcCtD
Methadone—Lung disorder—Doxorubicin—uterine cancer	0.000368	0.00396	CcSEcCtD
Methadone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000364	0.00392	CcSEcCtD
Methadone—Anxiety—Progesterone—uterine cancer	0.000364	0.00392	CcSEcCtD
Methadone—CYP1A2—renal system—uterine cancer	0.000363	0.014	CbGeAlD
Methadone—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.00384	CcSEcCtD
Methadone—Dry mouth—Progesterone—uterine cancer	0.000357	0.00384	CcSEcCtD
Methadone—Confusional state—Progesterone—uterine cancer	0.000353	0.0038	CcSEcCtD
Methadone—Oedema—Progesterone—uterine cancer	0.00035	0.00377	CcSEcCtD
Methadone—Anaphylactic shock—Progesterone—uterine cancer	0.00035	0.00377	CcSEcCtD
Methadone—CYP3A5—renal system—uterine cancer	0.00035	0.0135	CbGeAlD
Methadone—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000349	0.00376	CcSEcCtD
Methadone—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000349	0.00375	CcSEcCtD
Methadone—CYP2B6—renal system—uterine cancer	0.000348	0.0134	CbGeAlD
Methadone—Cardiac arrest—Etoposide—uterine cancer	0.000346	0.00373	CcSEcCtD
Methadone—Shock—Progesterone—uterine cancer	0.000344	0.00371	CcSEcCtD
Methadone—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.0037	CcSEcCtD
Methadone—Tachycardia—Progesterone—uterine cancer	0.000342	0.00368	CcSEcCtD
Methadone—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000342	0.00368	CcSEcCtD
Methadone—Hyperhidrosis—Progesterone—uterine cancer	0.000338	0.00364	CcSEcCtD
Methadone—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000337	0.00362	CcSEcCtD
Methadone—Anorexia—Progesterone—uterine cancer	0.000334	0.00359	CcSEcCtD
Methadone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00033	0.00355	CcSEcCtD
Methadone—Hypotension—Progesterone—uterine cancer	0.000327	0.00352	CcSEcCtD
Methadone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000324	0.00348	CcSEcCtD
Methadone—Flushing—Dactinomycin—uterine cancer	0.000323	0.00348	CcSEcCtD
Methadone—CYP2C19—vagina—uterine cancer	0.000322	0.0124	CbGeAlD
Methadone—Amenorrhoea—Epirubicin—uterine cancer	0.00032	0.00344	CcSEcCtD
Methadone—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00032	0.00344	CcSEcCtD
Methadone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00341	CcSEcCtD
Methadone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000317	0.00341	CcSEcCtD
Methadone—Insomnia—Progesterone—uterine cancer	0.000317	0.00341	CcSEcCtD
Methadone—Chills—Dactinomycin—uterine cancer	0.000312	0.00336	CcSEcCtD
Methadone—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000312	0.00336	CcSEcCtD
Methadone—Somnolence—Progesterone—uterine cancer	0.000311	0.00335	CcSEcCtD
Methadone—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000311	0.00334	CcSEcCtD
Methadone—CYP2C8—female reproductive system—uterine cancer	0.00031	0.012	CbGeAlD
Methadone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00333	CcSEcCtD
Methadone—Sweating increased—Etoposide—uterine cancer	0.000307	0.0033	CcSEcCtD
Methadone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000307	0.0033	CcSEcCtD
Methadone—Lacrimation increased—Epirubicin—uterine cancer	0.000305	0.00328	CcSEcCtD
Methadone—Glossitis—Epirubicin—uterine cancer	0.000305	0.00328	CcSEcCtD
Methadone—Decreased appetite—Progesterone—uterine cancer	0.000304	0.00327	CcSEcCtD
Methadone—Erythema—Dactinomycin—uterine cancer	0.000303	0.00326	CcSEcCtD
Methadone—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.00325	CcSEcCtD
Methadone—Constipation—Progesterone—uterine cancer	0.000299	0.00322	CcSEcCtD
Methadone—Pain—Progesterone—uterine cancer	0.000299	0.00322	CcSEcCtD
Methadone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000296	0.00319	CcSEcCtD
Methadone—Amenorrhoea—Doxorubicin—uterine cancer	0.000296	0.00319	CcSEcCtD
Methadone—Clotrimazole—CYP19A1—uterine cancer	0.000294	0.168	CrCbGaD
Methadone—Levomethadyl Acetate—CYP19A1—uterine cancer	0.000294	0.168	CrCbGaD
Methadone—Feeling abnormal—Progesterone—uterine cancer	0.000288	0.0031	CcSEcCtD
Methadone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000287	0.00309	CcSEcCtD
Methadone—Gastrointestinal pain—Progesterone—uterine cancer	0.000286	0.00308	CcSEcCtD
Methadone—Lacrimation increased—Doxorubicin—uterine cancer	0.000283	0.00304	CcSEcCtD
Methadone—Glossitis—Doxorubicin—uterine cancer	0.000283	0.00304	CcSEcCtD
Methadone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.00303	CcSEcCtD
Methadone—Ventricular tachycardia—Epirubicin—uterine cancer	0.000281	0.00303	CcSEcCtD
Methadone—CYP2C8—vagina—uterine cancer	0.000281	0.0108	CbGeAlD
Methadone—CYP2B6—female reproductive system—uterine cancer	0.000278	0.0107	CbGeAlD
Methadone—Urticaria—Progesterone—uterine cancer	0.000278	0.00299	CcSEcCtD
Methadone—Dermatitis contact—Epirubicin—uterine cancer	0.000278	0.00299	CcSEcCtD
Methadone—Body temperature increased—Progesterone—uterine cancer	0.000277	0.00298	CcSEcCtD
Methadone—Abdominal pain—Progesterone—uterine cancer	0.000277	0.00298	CcSEcCtD
Methadone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000276	0.00297	CcSEcCtD
Methadone—CYP2C9—female reproductive system—uterine cancer	0.000276	0.0106	CbGeAlD
Methadone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000271	0.00292	CcSEcCtD
Methadone—CYP3A4—renal system—uterine cancer	0.000263	0.0101	CbGeAlD
Methadone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000261	0.00281	CcSEcCtD
Methadone—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00026	0.0028	CcSEcCtD
Methadone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000259	0.00279	CcSEcCtD
Methadone—Tamoxifen—ESR2—uterine cancer	0.000259	0.148	CrCbGaD
Methadone—CYP2D6—renal system—uterine cancer	0.000258	0.00995	CbGeAlD
Methadone—Hypersensitivity—Progesterone—uterine cancer	0.000258	0.00277	CcSEcCtD
Methadone—Dermatitis contact—Doxorubicin—uterine cancer	0.000257	0.00277	CcSEcCtD
Methadone—ABCB1—myometrium—uterine cancer	0.000255	0.00984	CbGeAlD
Methadone—CYP3A5—female gonad—uterine cancer	0.000255	0.00982	CbGeAlD
Methadone—CYP19A1—lymph node—uterine cancer	0.000254	0.00977	CbGeAlD
Methadone—CYP3A5—vagina—uterine cancer	0.000253	0.00976	CbGeAlD
Methadone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00271	CcSEcCtD
Methadone—CYP2B6—vagina—uterine cancer	0.000252	0.0097	CbGeAlD
Methadone—Asthenia—Progesterone—uterine cancer	0.000251	0.0027	CcSEcCtD
Methadone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000251	0.0027	CcSEcCtD
Methadone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000251	0.0027	CcSEcCtD
Methadone—Pulmonary oedema—Epirubicin—uterine cancer	0.00025	0.00269	CcSEcCtD
Methadone—Pruritus—Progesterone—uterine cancer	0.000248	0.00266	CcSEcCtD
Methadone—Oedema—Dactinomycin—uterine cancer	0.000247	0.00266	CcSEcCtD
Methadone—Thrombocytopenia—Dactinomycin—uterine cancer	0.000242	0.00261	CcSEcCtD
Methadone—Diarrhoea—Progesterone—uterine cancer	0.00024	0.00258	CcSEcCtD
Methadone—Phlebitis—Epirubicin—uterine cancer	0.000237	0.00255	CcSEcCtD
Methadone—Anorexia—Dactinomycin—uterine cancer	0.000236	0.00254	CcSEcCtD
Methadone—Flushing—Etoposide—uterine cancer	0.000234	0.00252	CcSEcCtD
Methadone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000234	0.00251	CcSEcCtD
Methadone—Pulmonary oedema—Doxorubicin—uterine cancer	0.000232	0.00249	CcSEcCtD
Methadone—Dizziness—Progesterone—uterine cancer	0.000231	0.00249	CcSEcCtD
Methadone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000228	0.00245	CcSEcCtD
Methadone—Chills—Etoposide—uterine cancer	0.000226	0.00243	CcSEcCtD
Methadone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000224	0.00241	CcSEcCtD
Methadone—Vomiting—Progesterone—uterine cancer	0.000223	0.00239	CcSEcCtD
Methadone—Rash—Progesterone—uterine cancer	0.000221	0.00237	CcSEcCtD
Methadone—Dermatitis—Progesterone—uterine cancer	0.000221	0.00237	CcSEcCtD
Methadone—Phlebitis—Doxorubicin—uterine cancer	0.000219	0.00236	CcSEcCtD
Methadone—Headache—Progesterone—uterine cancer	0.000219	0.00236	CcSEcCtD
Methadone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000217	0.00234	CcSEcCtD
Methadone—Decreased appetite—Dactinomycin—uterine cancer	0.000215	0.00231	CcSEcCtD
Methadone—Pain—Dactinomycin—uterine cancer	0.000212	0.00228	CcSEcCtD
Methadone—Muscle spasms—Etoposide—uterine cancer	0.000211	0.00227	CcSEcCtD
Methadone—CYP3A4—female reproductive system—uterine cancer	0.00021	0.0081	CbGeAlD
Methadone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00226	CcSEcCtD
Methadone—Cardiac failure—Epirubicin—uterine cancer	0.000209	0.00225	CcSEcCtD
Methadone—Nausea—Progesterone—uterine cancer	0.000208	0.00224	CcSEcCtD
Methadone—CYP2D6—female reproductive system—uterine cancer	0.000207	0.00797	CbGeAlD
Methadone—Feeling abnormal—Dactinomycin—uterine cancer	0.000204	0.00219	CcSEcCtD
Methadone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000202	0.00218	CcSEcCtD
Methadone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000202	0.00217	CcSEcCtD
Methadone—ABCB1—epithelium—uterine cancer	0.0002	0.00772	CbGeAlD
Methadone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.00215	CcSEcCtD
Methadone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0002	0.00215	CcSEcCtD
Methadone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000199	0.00214	CcSEcCtD
Methadone—ABCB1—uterine cervix—uterine cancer	0.000199	0.00765	CbGeAlD
Methadone—Vertigo—Etoposide—uterine cancer	0.000197	0.00212	CcSEcCtD
Methadone—Abdominal pain—Dactinomycin—uterine cancer	0.000196	0.0021	CcSEcCtD
Methadone—Body temperature increased—Dactinomycin—uterine cancer	0.000196	0.0021	CcSEcCtD
Methadone—Cardiac arrest—Epirubicin—uterine cancer	0.000194	0.00209	CcSEcCtD
Methadone—Cardiac failure—Doxorubicin—uterine cancer	0.000194	0.00208	CcSEcCtD
Methadone—Loss of consciousness—Etoposide—uterine cancer	0.000193	0.00207	CcSEcCtD
Methadone—Convulsion—Etoposide—uterine cancer	0.00019	0.00205	CcSEcCtD
Methadone—ABCB1—decidua—uterine cancer	0.000189	0.00729	CbGeAlD
Methadone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.00203	CcSEcCtD
Methadone—CYP2D6—female gonad—uterine cancer	0.000188	0.00725	CbGeAlD
Methadone—Orthostatic hypotension—Epirubicin—uterine cancer	0.000187	0.00201	CcSEcCtD
Methadone—Hypokalaemia—Epirubicin—uterine cancer	0.000186	0.002	CcSEcCtD
Methadone—ABCB1—renal system—uterine cancer	0.000186	0.00716	CbGeAlD
Methadone—Nasopharyngitis—Epirubicin—uterine cancer	0.000183	0.00196	CcSEcCtD
Methadone—Hypersensitivity—Dactinomycin—uterine cancer	0.000182	0.00196	CcSEcCtD
Methadone—Confusional state—Etoposide—uterine cancer	0.000181	0.00194	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—uterine cancer	0.00018	0.00193	CcSEcCtD
Methadone—ABCB1—endometrium—uterine cancer	0.00018	0.00692	CbGeAlD
Methadone—Anaphylactic shock—Etoposide—uterine cancer	0.000179	0.00193	CcSEcCtD
Methadone—Asthenia—Dactinomycin—uterine cancer	0.000178	0.00191	CcSEcCtD
Methadone—Thrombocytopenia—Etoposide—uterine cancer	0.000175	0.00189	CcSEcCtD
Methadone—Tachycardia—Etoposide—uterine cancer	0.000175	0.00188	CcSEcCtD
Methadone—ABCB1—mammalian vulva—uterine cancer	0.000174	0.0067	CbGeAlD
Methadone—Tamoxifen—CYP19A1—uterine cancer	0.000174	0.0993	CrCbGaD
Methadone—Hyperhidrosis—Etoposide—uterine cancer	0.000173	0.00186	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000173	0.00186	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—uterine cancer	0.000172	0.00185	CcSEcCtD
Methadone—Anorexia—Etoposide—uterine cancer	0.000171	0.00184	CcSEcCtD
Methadone—Diarrhoea—Dactinomycin—uterine cancer	0.000169	0.00182	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—uterine cancer	0.000169	0.00182	CcSEcCtD
Methadone—Hypotension—Etoposide—uterine cancer	0.000167	0.0018	CcSEcCtD
Methadone—ABCB1—uterus—uterine cancer	0.000166	0.00638	CbGeAlD
Methadone—Weight increased—Epirubicin—uterine cancer	0.000161	0.00173	CcSEcCtD
Methadone—Tamoxifen—ESR1—uterine cancer	0.00016	0.0914	CrCbGaD
Methadone—Weight decreased—Epirubicin—uterine cancer	0.00016	0.00172	CcSEcCtD
Methadone—Somnolence—Etoposide—uterine cancer	0.000159	0.00171	CcSEcCtD
Methadone—Drowsiness—Epirubicin—uterine cancer	0.000157	0.00169	CcSEcCtD
Methadone—Vomiting—Dactinomycin—uterine cancer	0.000157	0.00169	CcSEcCtD
Methadone—Rash—Dactinomycin—uterine cancer	0.000156	0.00168	CcSEcCtD
Methadone—Decreased appetite—Etoposide—uterine cancer	0.000156	0.00167	CcSEcCtD
Methadone—Constipation—Etoposide—uterine cancer	0.000153	0.00165	CcSEcCtD
Methadone—Pain—Etoposide—uterine cancer	0.000153	0.00165	CcSEcCtD
Methadone—Sweating—Epirubicin—uterine cancer	0.000151	0.00162	CcSEcCtD
Methadone—ABCB1—female reproductive system—uterine cancer	0.000149	0.00573	CbGeAlD
Methadone—Weight increased—Doxorubicin—uterine cancer	0.000149	0.0016	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—uterine cancer	0.000148	0.00159	CcSEcCtD
Methadone—Feeling abnormal—Etoposide—uterine cancer	0.000148	0.00159	CcSEcCtD
Methadone—Nausea—Dactinomycin—uterine cancer	0.000147	0.00158	CcSEcCtD
Methadone—Gastrointestinal pain—Etoposide—uterine cancer	0.000146	0.00158	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—uterine cancer	0.000146	0.00157	CcSEcCtD
Methadone—Bradycardia—Epirubicin—uterine cancer	0.000144	0.00155	CcSEcCtD
Methadone—Urticaria—Etoposide—uterine cancer	0.000142	0.00153	CcSEcCtD
Methadone—Abdominal pain—Etoposide—uterine cancer	0.000142	0.00152	CcSEcCtD
Methadone—Body temperature increased—Etoposide—uterine cancer	0.000142	0.00152	CcSEcCtD
Methadone—Sweating—Doxorubicin—uterine cancer	0.00014	0.0015	CcSEcCtD
Methadone—Visual impairment—Epirubicin—uterine cancer	0.000136	0.00146	CcSEcCtD
Methadone—ABCB1—female gonad—uterine cancer	0.000135	0.00522	CbGeAlD
Methadone—ABCB1—vagina—uterine cancer	0.000135	0.00519	CbGeAlD
Methadone—Bradycardia—Doxorubicin—uterine cancer	0.000133	0.00143	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—uterine cancer	0.000132	0.00142	CcSEcCtD
Methadone—Flushing—Epirubicin—uterine cancer	0.000131	0.00141	CcSEcCtD
Methadone—Asthenia—Etoposide—uterine cancer	0.000128	0.00138	CcSEcCtD
Methadone—Chills—Epirubicin—uterine cancer	0.000127	0.00136	CcSEcCtD
Methadone—Pruritus—Etoposide—uterine cancer	0.000127	0.00136	CcSEcCtD
Methadone—Arrhythmia—Epirubicin—uterine cancer	0.000126	0.00136	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—uterine cancer	0.000126	0.00136	CcSEcCtD
Methadone—Erythema—Epirubicin—uterine cancer	0.000123	0.00132	CcSEcCtD
Methadone—Diarrhoea—Etoposide—uterine cancer	0.000123	0.00132	CcSEcCtD
Methadone—Flushing—Doxorubicin—uterine cancer	0.000121	0.00131	CcSEcCtD
Methadone—Dizziness—Etoposide—uterine cancer	0.000118	0.00127	CcSEcCtD
Methadone—Muscle spasms—Epirubicin—uterine cancer	0.000118	0.00127	CcSEcCtD
Methadone—Chills—Doxorubicin—uterine cancer	0.000117	0.00126	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—uterine cancer	0.000117	0.00126	CcSEcCtD
Methadone—Vomiting—Etoposide—uterine cancer	0.000114	0.00122	CcSEcCtD
Methadone—Erythema—Doxorubicin—uterine cancer	0.000114	0.00122	CcSEcCtD
Methadone—Agitation—Epirubicin—uterine cancer	0.000113	0.00122	CcSEcCtD
Methadone—Rash—Etoposide—uterine cancer	0.000113	0.00121	CcSEcCtD
Methadone—Dermatitis—Etoposide—uterine cancer	0.000113	0.00121	CcSEcCtD
Methadone—Headache—Etoposide—uterine cancer	0.000112	0.00121	CcSEcCtD
Methadone—Vertigo—Epirubicin—uterine cancer	0.000111	0.00119	CcSEcCtD
Methadone—Syncope—Epirubicin—uterine cancer	0.00011	0.00119	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—uterine cancer	0.000109	0.00118	CcSEcCtD
Methadone—Palpitations—Epirubicin—uterine cancer	0.000109	0.00117	CcSEcCtD
Methadone—Loss of consciousness—Epirubicin—uterine cancer	0.000108	0.00116	CcSEcCtD
Methadone—Convulsion—Epirubicin—uterine cancer	0.000107	0.00115	CcSEcCtD
Methadone—Nausea—Etoposide—uterine cancer	0.000106	0.00114	CcSEcCtD
Methadone—Agitation—Doxorubicin—uterine cancer	0.000105	0.00113	CcSEcCtD
Methadone—Anxiety—Epirubicin—uterine cancer	0.000104	0.00112	CcSEcCtD
Methadone—Dry mouth—Epirubicin—uterine cancer	0.000102	0.0011	CcSEcCtD
Methadone—Vertigo—Doxorubicin—uterine cancer	0.000102	0.0011	CcSEcCtD
Methadone—Syncope—Doxorubicin—uterine cancer	0.000102	0.0011	CcSEcCtD
Methadone—Confusional state—Epirubicin—uterine cancer	0.000101	0.00109	CcSEcCtD
Methadone—Palpitations—Doxorubicin—uterine cancer	0.000101	0.00108	CcSEcCtD
Methadone—Anaphylactic shock—Epirubicin—uterine cancer	0.0001	0.00108	CcSEcCtD
Methadone—Oedema—Epirubicin—uterine cancer	0.0001	0.00108	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—uterine cancer	0.0001	0.00108	CcSEcCtD
Methadone—Shock—Epirubicin—uterine cancer	9.88e-05	0.00106	CcSEcCtD
Methadone—Convulsion—Doxorubicin—uterine cancer	9.86e-05	0.00106	CcSEcCtD
Methadone—Thrombocytopenia—Epirubicin—uterine cancer	9.83e-05	0.00106	CcSEcCtD
Methadone—Tachycardia—Epirubicin—uterine cancer	9.8e-05	0.00105	CcSEcCtD
Methadone—Hyperhidrosis—Epirubicin—uterine cancer	9.7e-05	0.00104	CcSEcCtD
Methadone—Anxiety—Doxorubicin—uterine cancer	9.66e-05	0.00104	CcSEcCtD
Methadone—Anorexia—Epirubicin—uterine cancer	9.57e-05	0.00103	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—uterine cancer	9.48e-05	0.00102	CcSEcCtD
Methadone—Hypotension—Epirubicin—uterine cancer	9.38e-05	0.00101	CcSEcCtD
Methadone—Confusional state—Doxorubicin—uterine cancer	9.37e-05	0.00101	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—uterine cancer	9.29e-05	0.000999	CcSEcCtD
Methadone—Oedema—Doxorubicin—uterine cancer	9.29e-05	0.000999	CcSEcCtD
Methadone—Shock—Doxorubicin—uterine cancer	9.14e-05	0.000983	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—uterine cancer	9.09e-05	0.000978	CcSEcCtD
Methadone—Insomnia—Epirubicin—uterine cancer	9.08e-05	0.000977	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—uterine cancer	9.07e-05	0.000975	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—uterine cancer	8.98e-05	0.000966	CcSEcCtD
Methadone—Somnolence—Epirubicin—uterine cancer	8.92e-05	0.00096	CcSEcCtD
Methadone—Anorexia—Doxorubicin—uterine cancer	8.85e-05	0.000952	CcSEcCtD
Methadone—Decreased appetite—Epirubicin—uterine cancer	8.73e-05	0.000939	CcSEcCtD
Methadone—ABCB1—lymph node—uterine cancer	8.71e-05	0.00335	CbGeAlD
Methadone—Hypotension—Doxorubicin—uterine cancer	8.68e-05	0.000934	CcSEcCtD
Methadone—Constipation—Epirubicin—uterine cancer	8.58e-05	0.000924	CcSEcCtD
Methadone—Pain—Epirubicin—uterine cancer	8.58e-05	0.000924	CcSEcCtD
Methadone—Insomnia—Doxorubicin—uterine cancer	8.4e-05	0.000904	CcSEcCtD
Methadone—Feeling abnormal—Epirubicin—uterine cancer	8.27e-05	0.00089	CcSEcCtD
Methadone—Somnolence—Doxorubicin—uterine cancer	8.26e-05	0.000888	CcSEcCtD
Methadone—Gastrointestinal pain—Epirubicin—uterine cancer	8.21e-05	0.000883	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—uterine cancer	8.07e-05	0.000869	CcSEcCtD
Methadone—Urticaria—Epirubicin—uterine cancer	7.97e-05	0.000858	CcSEcCtD
Methadone—Pain—Doxorubicin—uterine cancer	7.94e-05	0.000855	CcSEcCtD
Methadone—Constipation—Doxorubicin—uterine cancer	7.94e-05	0.000855	CcSEcCtD
Methadone—Abdominal pain—Epirubicin—uterine cancer	7.94e-05	0.000854	CcSEcCtD
Methadone—Body temperature increased—Epirubicin—uterine cancer	7.94e-05	0.000854	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—uterine cancer	7.65e-05	0.000823	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—uterine cancer	7.6e-05	0.000817	CcSEcCtD
Methadone—Hypersensitivity—Epirubicin—uterine cancer	7.4e-05	0.000796	CcSEcCtD
Methadone—Urticaria—Doxorubicin—uterine cancer	7.38e-05	0.000794	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—uterine cancer	7.34e-05	0.00079	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—uterine cancer	7.34e-05	0.00079	CcSEcCtD
Methadone—Asthenia—Epirubicin—uterine cancer	7.2e-05	0.000775	CcSEcCtD
Methadone—Pruritus—Epirubicin—uterine cancer	7.1e-05	0.000764	CcSEcCtD
Methadone—Diarrhoea—Epirubicin—uterine cancer	6.87e-05	0.000739	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—uterine cancer	6.84e-05	0.000736	CcSEcCtD
Methadone—Asthenia—Doxorubicin—uterine cancer	6.66e-05	0.000717	CcSEcCtD
Methadone—Dizziness—Epirubicin—uterine cancer	6.64e-05	0.000714	CcSEcCtD
Methadone—Pruritus—Doxorubicin—uterine cancer	6.57e-05	0.000707	CcSEcCtD
Methadone—Vomiting—Epirubicin—uterine cancer	6.38e-05	0.000687	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—uterine cancer	6.36e-05	0.000684	CcSEcCtD
Methadone—Rash—Epirubicin—uterine cancer	6.33e-05	0.000681	CcSEcCtD
Methadone—Dermatitis—Epirubicin—uterine cancer	6.32e-05	0.00068	CcSEcCtD
Methadone—Headache—Epirubicin—uterine cancer	6.29e-05	0.000677	CcSEcCtD
Methadone—Dizziness—Doxorubicin—uterine cancer	6.14e-05	0.000661	CcSEcCtD
Methadone—Nausea—Epirubicin—uterine cancer	5.96e-05	0.000641	CcSEcCtD
Methadone—Vomiting—Doxorubicin—uterine cancer	5.91e-05	0.000635	CcSEcCtD
Methadone—Rash—Doxorubicin—uterine cancer	5.86e-05	0.00063	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—uterine cancer	5.85e-05	0.000629	CcSEcCtD
Methadone—Headache—Doxorubicin—uterine cancer	5.82e-05	0.000626	CcSEcCtD
Methadone—Nausea—Doxorubicin—uterine cancer	5.52e-05	0.000594	CcSEcCtD
Methadone—CYP2C9—Metabolism—STAR—uterine cancer	1.03e-05	0.000423	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—STK11—uterine cancer	1.02e-05	0.000421	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STK11—uterine cancer	1.02e-05	0.000421	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL2—uterine cancer	1.02e-05	0.000419	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.02e-05	0.000418	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IGF1R—uterine cancer	1.01e-05	0.000417	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CXCL8—uterine cancer	1.01e-05	0.000416	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—MTHFR—uterine cancer	1e-05	0.000413	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POLD1—uterine cancer	9.91e-06	0.000408	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FBXW7—uterine cancer	9.88e-06	0.000407	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.84e-06	0.000405	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—RRM2—uterine cancer	9.76e-06	0.000402	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.6e-06	0.000395	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SOCS3—uterine cancer	9.57e-06	0.000394	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—RRM2—uterine cancer	9.54e-06	0.000393	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SMAD3—uterine cancer	9.54e-06	0.000393	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—DCN—uterine cancer	9.48e-06	0.00039	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.38e-06	0.000386	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.38e-06	0.000386	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKR1C1—uterine cancer	9.27e-06	0.000382	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—DCN—uterine cancer	9.26e-06	0.000381	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CXCL8—uterine cancer	9.17e-06	0.000377	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN2B—uterine cancer	9.16e-06	0.000377	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.16e-06	0.000377	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—FGFR2—uterine cancer	9.1e-06	0.000374	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP11A1—uterine cancer	8.93e-06	0.000367	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IGF1R—uterine cancer	8.89e-06	0.000366	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—STK11—uterine cancer	8.88e-06	0.000366	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CYP19A1—uterine cancer	8.88e-06	0.000366	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CXCL8—uterine cancer	8.86e-06	0.000364	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POLD1—uterine cancer	8.85e-06	0.000364	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—STAR—uterine cancer	8.79e-06	0.000362	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKR1B1—uterine cancer	8.79e-06	0.000362	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP11A1—uterine cancer	8.73e-06	0.000359	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.68e-06	0.000357	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POLD1—uterine cancer	8.64e-06	0.000355	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STK11—uterine cancer	8.64e-06	0.000355	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL2—uterine cancer	8.6e-06	0.000354	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKR1C3—uterine cancer	8.43e-06	0.000347	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SMAD3—uterine cancer	8.36e-06	0.000344	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	8.36e-06	0.000344	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKR1C1—uterine cancer	8.28e-06	0.000341	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—RRM2—uterine cancer	8.26e-06	0.00034	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKR1C3—uterine cancer	8.24e-06	0.000339	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POLD1—uterine cancer	8.14e-06	0.000335	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SOCS3—uterine cancer	8.09e-06	0.000333	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKR1C1—uterine cancer	8.08e-06	0.000332	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POLD1—uterine cancer	8.07e-06	0.000332	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL8—uterine cancer	8.04e-06	0.000331	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—DCN—uterine cancer	8.02e-06	0.00033	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—FGFR2—uterine cancer	7.98e-06	0.000328	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ESR1—uterine cancer	7.78e-06	0.00032	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN2B—uterine cancer	7.74e-06	0.000319	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—MTHFR—uterine cancer	7.69e-06	0.000316	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.68e-06	0.000316	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKR1C1—uterine cancer	7.61e-06	0.000313	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP11A1—uterine cancer	7.56e-06	0.000311	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKR1C1—uterine cancer	7.55e-06	0.000311	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IGF1R—uterine cancer	7.52e-06	0.000309	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL8—uterine cancer	7.48e-06	0.000308	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.43e-06	0.000306	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—RRM2—uterine cancer	7.38e-06	0.000304	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—NRAS—uterine cancer	7.36e-06	0.000303	CbGpPWpGaD
Methadone—ABCB1—Metabolism—RRM2—uterine cancer	7.2e-06	0.000296	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—DCN—uterine cancer	7.16e-06	0.000295	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKR1C3—uterine cancer	7.14e-06	0.000294	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SMAD3—uterine cancer	7.07e-06	0.000291	CbGpPWpGaD
Methadone—ABCB1—Metabolism—DCN—uterine cancer	6.99e-06	0.000288	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POLD1—uterine cancer	6.89e-06	0.000284	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL2—uterine cancer	6.85e-06	0.000282	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ESR1—uterine cancer	6.82e-06	0.000281	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL8—uterine cancer	6.8e-06	0.00028	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—RRM2—uterine cancer	6.78e-06	0.000279	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.78e-06	0.000279	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—STAR—uterine cancer	6.78e-06	0.000279	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.77e-06	0.000279	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP11A1—uterine cancer	6.75e-06	0.000278	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—FGFR2—uterine cancer	6.74e-06	0.000277	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—RRM2—uterine cancer	6.73e-06	0.000277	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—MTHFR—uterine cancer	6.67e-06	0.000275	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—DCN—uterine cancer	6.59e-06	0.000271	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP11A1—uterine cancer	6.59e-06	0.000271	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—STK11—uterine cancer	6.57e-06	0.00027	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP19A1—uterine cancer	6.57e-06	0.00027	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—DCN—uterine cancer	6.53e-06	0.000269	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—NRAS—uterine cancer	6.45e-06	0.000266	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKR1C1—uterine cancer	6.45e-06	0.000265	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—STK11—uterine cancer	6.42e-06	0.000264	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP19A1—uterine cancer	6.42e-06	0.000264	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—PIK3CA—uterine cancer	6.41e-06	0.000264	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKR1C3—uterine cancer	6.37e-06	0.000262	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—KRAS—uterine cancer	6.33e-06	0.000261	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.28e-06	0.000258	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKR1C3—uterine cancer	6.22e-06	0.000256	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP11A1—uterine cancer	6.21e-06	0.000255	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP11A1—uterine cancer	6.15e-06	0.000253	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL2—uterine cancer	6.01e-06	0.000247	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKR1C3—uterine cancer	5.86e-06	0.000241	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PIK3CA—uterine cancer	5.82e-06	0.000239	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.81e-06	0.000239	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ESR1—uterine cancer	5.77e-06	0.000237	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RRM2—uterine cancer	5.75e-06	0.000237	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ERBB2—uterine cancer	5.71e-06	0.000235	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PIK3CA—uterine cancer	5.62e-06	0.000231	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTEN—uterine cancer	5.59e-06	0.00023	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—DCN—uterine cancer	5.58e-06	0.00023	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP19A1—uterine cancer	5.56e-06	0.000229	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—STK11—uterine cancer	5.56e-06	0.000229	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—KRAS—uterine cancer	5.55e-06	0.000229	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—NRAS—uterine cancer	5.45e-06	0.000224	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—uterine cancer	5.42e-06	0.000223	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRAS—uterine cancer	5.38e-06	0.000222	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—EP300—uterine cancer	5.33e-06	0.000219	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POLD1—uterine cancer	5.32e-06	0.000219	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDKN1B—uterine cancer	5.29e-06	0.000218	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP11A1—uterine cancer	5.26e-06	0.000216	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—AKT1—uterine cancer	5.23e-06	0.000215	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.22e-06	0.000215	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PIK3CA—uterine cancer	5.1e-06	0.00021	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL2—uterine cancer	5.08e-06	0.000209	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ERBB2—uterine cancer	5.01e-06	0.000206	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CTNNB1—uterine cancer	5e-06	0.000206	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.98e-06	0.000205	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.98e-06	0.000205	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.96e-06	0.000204	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—STK11—uterine cancer	4.96e-06	0.000204	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP19A1—uterine cancer	4.96e-06	0.000204	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—MTHFR—uterine cancer	4.94e-06	0.000203	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTEN—uterine cancer	4.87e-06	0.0002	CbGpPWpGaD
Methadone—ABCB1—Metabolism—STK11—uterine cancer	4.84e-06	0.000199	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP19A1—uterine cancer	4.84e-06	0.000199	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—MTHFR—uterine cancer	4.82e-06	0.000199	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—AKT1—uterine cancer	4.75e-06	0.000196	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—uterine cancer	4.75e-06	0.000196	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—uterine cancer	4.75e-06	0.000195	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—uterine cancer	4.72e-06	0.000194	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—uterine cancer	4.69e-06	0.000193	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.66e-06	0.000192	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EP300—uterine cancer	4.65e-06	0.000191	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1B—uterine cancer	4.64e-06	0.000191	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—AKT1—uterine cancer	4.59e-06	0.000189	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—STK11—uterine cancer	4.57e-06	0.000188	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP19A1—uterine cancer	4.57e-06	0.000188	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.53e-06	0.000186	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—STK11—uterine cancer	4.53e-06	0.000186	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.44e-06	0.000183	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RRM2—uterine cancer	4.44e-06	0.000183	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—uterine cancer	4.4e-06	0.000181	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CTNNB1—uterine cancer	4.38e-06	0.00018	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—NRAS—uterine cancer	4.35e-06	0.000179	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—uterine cancer	4.31e-06	0.000177	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DCN—uterine cancer	4.31e-06	0.000177	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—uterine cancer	4.28e-06	0.000176	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—uterine cancer	4.27e-06	0.000176	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.25e-06	0.000175	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB2—uterine cancer	4.23e-06	0.000174	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—uterine cancer	4.18e-06	0.000172	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—AKT1—uterine cancer	4.17e-06	0.000172	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—EP300—uterine cancer	4.08e-06	0.000168	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EP300—uterine cancer	4.07e-06	0.000168	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.06e-06	0.000167	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.05e-06	0.000167	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—uterine cancer	4.01e-06	0.000165	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—uterine cancer	3.99e-06	0.000164	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—uterine cancer	3.94e-06	0.000162	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1B—uterine cancer	3.92e-06	0.000161	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—AKT1—uterine cancer	3.88e-06	0.00016	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.87e-06	0.000159	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—STK11—uterine cancer	3.87e-06	0.000159	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—uterine cancer	3.86e-06	0.000159	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.83e-06	0.000158	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NRAS—uterine cancer	3.81e-06	0.000157	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—uterine cancer	3.74e-06	0.000154	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—uterine cancer	3.73e-06	0.000154	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—uterine cancer	3.71e-06	0.000153	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CTNNB1—uterine cancer	3.7e-06	0.000152	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.68e-06	0.000152	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—uterine cancer	3.64e-06	0.00015	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.63e-06	0.000149	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—uterine cancer	3.61e-06	0.000149	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—EP300—uterine cancer	3.54e-06	0.000146	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—AKT1—uterine cancer	3.52e-06	0.000145	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.46e-06	0.000143	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EP300—uterine cancer	3.44e-06	0.000142	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—uterine cancer	3.44e-06	0.000141	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—uterine cancer	3.43e-06	0.000141	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—uterine cancer	3.4e-06	0.00014	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—uterine cancer	3.32e-06	0.000137	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.29e-06	0.000135	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—uterine cancer	3.28e-06	0.000135	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—uterine cancer	3.26e-06	0.000134	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NRAS—uterine cancer	3.22e-06	0.000133	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—AKT1—uterine cancer	3.22e-06	0.000132	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—uterine cancer	3.18e-06	0.000131	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—uterine cancer	3.02e-06	0.000124	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	3.01e-06	0.000124	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3e-06	0.000123	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—STK11—uterine cancer	2.98e-06	0.000123	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.98e-06	0.000123	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—uterine cancer	2.92e-06	0.00012	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—uterine cancer	2.91e-06	0.00012	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—AKT1—uterine cancer	2.81e-06	0.000116	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—uterine cancer	2.79e-06	0.000115	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—uterine cancer	2.77e-06	0.000114	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—uterine cancer	2.75e-06	0.000113	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—uterine cancer	2.68e-06	0.00011	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—uterine cancer	2.62e-06	0.000108	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—EP300—uterine cancer	2.62e-06	0.000108	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.56e-06	0.000105	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—EP300—uterine cancer	2.56e-06	0.000105	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	2.55e-06	0.000105	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—AKT1—uterine cancer	2.46e-06	0.000101	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—uterine cancer	2.46e-06	0.000101	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—AKT1—uterine cancer	2.46e-06	0.000101	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—uterine cancer	2.36e-06	9.7e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—uterine cancer	2.32e-06	9.57e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—uterine cancer	2.24e-06	9.23e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—EP300—uterine cancer	2.22e-06	9.13e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—AKT1—uterine cancer	2.14e-06	8.81e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—AKT1—uterine cancer	2.08e-06	8.56e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—uterine cancer	2.08e-06	8.54e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—uterine cancer	2.03e-06	8.34e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—EP300—uterine cancer	1.98e-06	8.14e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.94e-06	7.97e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—EP300—uterine cancer	1.93e-06	7.95e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—uterine cancer	1.91e-06	7.86e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.89e-06	7.79e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—uterine cancer	1.89e-06	7.79e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—EP300—uterine cancer	1.82e-06	7.49e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—EP300—uterine cancer	1.8e-06	7.43e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.64e-06	6.75e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—uterine cancer	1.62e-06	6.65e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—AKT1—uterine cancer	1.58e-06	6.51e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—AKT1—uterine cancer	1.55e-06	6.37e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—EP300—uterine cancer	1.54e-06	6.35e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.46e-06	6.03e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—uterine cancer	1.43e-06	5.88e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.35e-06	5.54e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—AKT1—uterine cancer	1.34e-06	5.51e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.33e-06	5.49e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—uterine cancer	1.25e-06	5.14e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—AKT1—uterine cancer	1.2e-06	4.92e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—EP300—uterine cancer	1.19e-06	4.9e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—AKT1—uterine cancer	1.17e-06	4.8e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.14e-06	4.69e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—AKT1—uterine cancer	1.1e-06	4.53e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKT1—uterine cancer	1.09e-06	4.49e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKT1—uterine cancer	9.32e-07	3.84e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.8e-07	3.62e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKT1—uterine cancer	7.19e-07	2.96e-05	CbGpPWpGaD
